Today: 9 June 2026
Why AngloGold Ashanti stock is rising today: gold rebounds as Fed minutes loom
30 December 2025
1 min read

Why AngloGold Ashanti stock is rising today: gold rebounds as Fed minutes loom

NEW YORK, December 30, 2025, 11:28 ET — Regular session

  • AngloGold Ashanti shares rose nearly 2% in late morning trading, tracking a bounce in gold prices.
  • Investors are focused on Federal Reserve minutes due at 2 p.m. ET for clues on 2026 rate policy.
  • AngloGold’s next scheduled catalyst is its year-end earnings release on Feb. 19, 2026.

AngloGold Ashanti plc shares rose 1.9% to $86.57 in late morning trading on Tuesday, as a rebound in gold helped lift mining stocks after a volatile start to the week.

The move matters now because miners often trade like “leveraged” bets on bullion. When gold moves, investors quickly reprice expected cash flow because many operating costs do not move day-to-day.

Tuesday’s rebound also comes with a major macro event on deck. Markets are braced for the release of Federal Reserve meeting minutes later in the session, which can shift bond yields and the dollar — two key drivers for gold.

Spot gold rose 0.8% to $4,365.86 an ounce at 9:56 a.m. ET, after Monday’s sharp pullback from Friday’s record high of $4,549.71, Reuters reported. “Things have stabilised somewhat today, the trade remains generally favourable,” said Peter Grant, vice president and senior metals strategist at Zaner Metals. Reuters

Gold is often treated as a safe-haven asset — something investors buy when they want to preserve value during stress. It also tends to benefit when interest rates fall, because gold does not pay interest.

Other gold-linked names moved higher alongside AngloGold. Newmont rose 1.6% and Gold Fields gained 1.2%, while the VanEck Gold Miners ETF added 1.6% and SPDR Gold Shares rose 0.4%.

The sector’s whipsaw followed a steep drop in precious metals on Monday. CME Group raised margin requirements — the cash traders must post to hold futures positions — a move that can force selling when prices swing sharply, Investopedia reported.

For miners, the takeaway is less about daily price ticks and more about whether gold holds onto its rebound. Sustained strength in bullion can widen profit margins, while renewed liquidation can hit miner shares quickly.

Investors will get the next macro read at 2 p.m. ET, when minutes from the Fed’s Dec. 9–10 meeting are released. The Fed cut rates to a 3.50%–3.75% range at that meeting, and the minutes are expected to shed light on divisions over the outlook for 2026 policy.

Bond yields and the dollar sit at the center of the trade. Rising yields can pressure gold by increasing the opportunity cost of holding it, while a weaker dollar can support bullion by making it cheaper for buyers using other currencies.

On the company calendar, AngloGold’s next scheduled catalyst is its year-end 2025 earnings release on Feb. 19, 2026, the company’s investor events calendar shows. Investors typically focus on production, costs and capital returns in those updates, especially when gold prices are volatile.

Stock Market Today

  • United Natural Foods Q3 Earnings Miss Estimates Despite Growth
    June 9, 2026, 10:13 AM EDT. United Natural Foods (UNFI) reported Q3 earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.81, marking a -5.34% earnings surprise. Revenues fell 2.02% short at $7.72 billion versus the expected $7.89 billion, down from $8.06 billion last year. The specialty foods distributor has beaten earnings estimates three times in the past four quarters but topped revenue estimates only once. UNFI shares have gained 53.4% year-to-date, far outpacing the S&P 500's 8.2% rise. The stock holds a Zacks Rank #3 (Hold), signaling expected in-line performance with the market amid mixed earnings estimate revisions. Industry outlook remains cautious with Food - Miscellaneous ranking in the bottom 16% according to Zacks.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop